Overview of Alzheimer’s Disease and Some Therapeutic Approaches Targeting Aβby Using Several Synthetic and Herbal Compounds
Open Access
- 28 December 2015
- journal article
- review article
- Published by Hindawi Limited in Oxidative Medicine and Cellular Longevity
- Vol. 2016, 1-22
- https://doi.org/10.1155/2016/7361613
Abstract
Alzheimer’s disease (AD) is a complex age-related neurodegenerative disease. In this review, we carefully detail amyloid-βmetabolism and its role in AD. We also consider the various genetic animal models used to evaluate therapeutics. Finally, we consider the role of synthetic and plant-based compounds in therapeutics.Keywords
Funding Information
- Indian Council of Medical Research (G12MD007591)
This publication has 156 references indexed in Scilit:
- Neuroprotective strategies involving ROS in Alzheimer diseaseFree Radical Biology & Medicine, 2011
- Alzheimer's Disease and tauopathy studies in flies and wormsNeurobiology of Disease, 2010
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- Amyloid precursor protein increases cortical neuron size in transgenic miceNeurobiology of Aging, 2009
- Netrin-1 interacts with amyloid precursor protein and regulates amyloid-β productionCell Death & Differentiation, 2009
- Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cellsThe Journal of Nutritional Biochemistry, 2008
- Disposition of Flavonoids via Enteric Recycling: Enzyme Stability Affects Characterization of Prunetin Glucuronidation across Species, Organs, and UGT IsoformsMolecular Pharmaceutics, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease geneNature, 1995
- β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityCell, 1995